乳房組織マーカーのグローバル市場(2022ー2031年):コイル形、リボン形、ボウタイ形、バタフライ形、U字形

• 英文タイトル:Breast Tissue Markers Market (Product: Coil, Ribbon, Bowtie, Butterfly, U Shape, and Others; and Material: Non-biodegradable and Partially Biodegradable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Breast Tissue Markers Market (Product: Coil, Ribbon, Bowtie, Butterfly, U Shape, and Others; and Material: Non-biodegradable and Partially Biodegradable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031「乳房組織マーカーのグローバル市場(2022ー2031年):コイル形、リボン形、ボウタイ形、バタフライ形、U字形」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2211A114
• 出版社/出版日:Transparency Market Research / 2022年9月
• レポート形態:英文、PDF、206ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界の乳房組織マーカー市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(コイル形、リボン形、ボウタイ形、バタフライ形、U字形)分析、材料別(非生分解性、部分的生分解性)分析、エンドユーザー別(病院、外来手術センター、診断センター、専門クリニック)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容を掲載しています。なお、当書には、Mammotome、BD、Hologic, Inc.、Carbon Medical Technologies, Inc.、Scion Medical Technologies, LLC、Mermaid Medical、SOMATEX Medical Technologies GmbHなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の乳房組織マーカー市場規模:製品別
- コイル形乳房組織マーカーの市場規模
- リボン形乳房組織マーカーの市場規模
- ボウタイ形乳房組織マーカーの市場規模
- バタフライ形乳房組織マーカーの市場規模
- U字形乳房組織マーカーの市場規模
・世界の乳房組織マーカー市場規模:材料別
- 非生分解性乳房組織マーカーの市場規模
- 部分的生分解性乳房組織マーカーの市場規模
・世界の乳房組織マーカー市場規模:エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- 診断センターにおける市場規模
- 専門クリニックにおける市場規模
・世界の乳房組織マーカー市場規模:地域別
- 北米の乳房組織マーカー市場規模
- ヨーロッパの乳房組織マーカー市場規模
- アジア太平洋の乳房組織マーカー市場規模
- 中南米の乳房組織マーカー市場規模
- 中東・アフリカの乳房組織マーカー市場規模
・競争状況

Breast Tissue Markers Market – Scope of Report

TMR’s report on the global breast tissue markers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global breast tissue markers market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global breast tissue markers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the breast tissue markers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global breast tissue markers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global breast tissue markers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global breast tissue markers market.

The report delves into the competitive landscape of the global breast tissue markers market. Key players operating in the global breast tissue markers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global breast tissue markers market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market breast tissue markers.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Tissue Markers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Tissue Markers Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key product/brand Analysis
5.2. Pipeline Analysis
5.3. Side Effects of Breast Tissue Markers
5.4. Patents
5.5. Key Mergers & Acquisitions
5.6. Pricing Analysis
5.7. Application of Clip Markers (outside mammography)
5.8. Breast Tissue Markers used per case
5.9. Disease Prevalence & Incidence Rate globally with key countries
5.10. COVID 19 Impact Analysis
6. Global Breast Tissue Markers Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Coil
6.3.2. Ribbon
6.3.3. Bowtie
6.3.4. Butterfly
6.3.5. Wing
6.3.6. U Shape
6.3.7. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Breast Tissue Markers Market Analysis and Forecast, By Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market ValueForecast, by Material, 2017 – 2031
7.3.1. Non-biodegradable
7.3.2. Partially Biodegradable
7.4. Market Attractiveness Analysis, by Material
8. Global Breast Tissue Markers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Diagnostic Centers
8.3.4. Specialty Clinics
8.4. Market Attractiveness Analysis, by End-user
9. Global Breast Tissue Markers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
10. North America Breast Tissue Markers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017 – 2031
10.2.1. Coil
10.2.2. Ribbon
10.2.3. Bowtie
10.2.4. Butterfly
10.2.5. Wing
10.2.6. U shape
10.2.7. Others
10.3. Market Value Forecast, by Material, 2017 – 2031
10.3.1. Non-biodegradable
10.3.2. Partially Biodegradable
10.4. Market Value Forecast, by End-user, 2017 – 2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Diagnostic Centers
10.4.4. Specialty Clinics
10.5. Market Value Forecast, by Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Material
10.6.3. By End-user
10.6.4. By Country
11. Europe Breast Tissue Markers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017 – 2031
11.2.1. Coil
11.2.2. Ribbon
11.2.3. Bowtie
11.2.4. Butterfly
11.2.5. Wing
11.2.6. U shape
11.2.7. Others
11.3. Market Value Forecast, by Material, 2017 – 2031
11.3.1. Non-biodegradable
11.3.2. Partially Biodegradable
11.4. Market Value Forecast, by End-user, 2017 – 2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Diagnostic Centers
11.4.4. Specialty Clinics
11.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Material
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Latin America Breast Tissue Markers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017 – 2031
12.2.1. Coil
12.2.2. Ribbon
12.2.3. Bowtie
12.2.4. Butterfly
12.2.5. Wing
12.2.6. U shape
12.2.7. Others
12.3. Market Value Forecast, by Material, 2017 – 2031
12.3.1. Non-biodegradable
12.3.2. Partially Biodegradable
12.4. Market Value Forecast, by End-user, 2017 – 2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Diagnostic Centers
12.4.4. Specialty Clinics
12.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By Degree of Cooling
12.6.4. By Country/Sub-region
13. Middle East & Africa Breast Tissue Markers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017 – 2031
13.2.1. Coil
13.2.2. Ribbon
13.2.3. Bowtie
13.2.4. Butterfly
13.2.5. Wing
13.2.6. U shape
13.2.7. Others
13.3. Market Value Forecast, by Material, 2017 – 2031
13.3.1. Non-biodegradable
13.3.2. Partially Biodegradable
13.4. Market Value Forecast, by End-user, 2017 – 2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Diagnostic Centers
13.4.4. Specialty Clinics
13.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By Degree of Cooling
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. Mammotome
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. BD
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Hologic, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Carbon Medical Technologies, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Scion Medical Technologies, LLC
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Mermaid Medical
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. SOMATEX Medical Technologies GmbH
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis

List of Tables

Table 01: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 03: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Breast Tissue Markers Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 08: North America Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 12: Europe Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 16: Asia Pacific Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 20: Latin America Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 24: Middle East & Africa Breast Tissue Markers Market Value (US$ Mn) Forecast, by End-user, 2017–2031


• 英文レポート名:Breast Tissue Markers Market (Product: Coil, Ribbon, Bowtie, Butterfly, U Shape, and Others; and Material: Non-biodegradable and Partially Biodegradable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
• 日本語訳:乳房組織マーカーのグローバル市場(2022ー2031年):コイル形、リボン形、ボウタイ形、バタフライ形、U字形
• レポートコード:MRC2211A114お問い合わせ(見積依頼・ご注文・質問)